CORC  > 复旦大学上海医学院
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
Liu, Zheng; Zhu, Yu; Xu, Le; Zhang, Junyu; Xie, Huyang; Fu, Hangcheng; Zhou, Quan; Chang, Yuan; Dai, Bo; Xu, Jiejie
刊名ONCOIMMUNOLOGY
2018
卷号7期号:9
关键词adjuvant chemotherapy bladder cancer mast cells overall survival prognosis recurrence-free survival
ISSN号2162-402X
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3606162
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Liu, Zheng,Zhu, Yu,Xu, Le,et al. Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer[J]. ONCOIMMUNOLOGY,2018,7(9).
APA Liu, Zheng.,Zhu, Yu.,Xu, Le.,Zhang, Junyu.,Xie, Huyang.,...&Xu, Jiejie.(2018).Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer.ONCOIMMUNOLOGY,7(9).
MLA Liu, Zheng,et al."Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer".ONCOIMMUNOLOGY 7.9(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace